secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001104659-23-106087
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus enters $30M standby equity purchase agreement with Yorkville; authorizes up to $4M warrant repurchase
--------------------------------------------------------------------------------

- Entered Standby Equity Purchase Agreement to sell up to $30M common stock to Yorkville at 96-97% of VWAP.
- Paid $25,000 structuring fee and $300,000 commitment fee; registration statement required before sales.
- Board authorized repurchase of publicly-held warrants for up to $4 million.
- Advances capped by 4.99% ownership limit and 19.99% exchange cap on outstanding stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923106087/0001104659-23-106087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465923106087/tm2327123d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-106087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer